AVX754
| CAS No. | 160707-69-7 | Cat. No. | BCP07907 |
| Name | AVX754 | ||
| Synonyms | Apricitabine;AVX-754;BCH10618;AVX 754;BCH-10618;BCH 10618; | ||
| Formula | C8H11N3O3S | M. Wt | 229.26 |
| Description | Apricitabine, also known as (-)-BCH-10652; (-)-dOTC; AVX-754; BCH-10618; SPD-754, is an experimental nucleoside reverse transcriptase inhibitor (NRTI) against HIV. It is structurally related to lamivudine and emtricitabine, and, like these, is an analogue of cytidine. | ||
| Pathways | Microbiology/Virology | ||
| Targets | Reverse Transcriptase HIV | ||
Structure
Part data of this page collected from the open network resources, so Biochempartner can not guarantee its accuracy.
For product details of different batches, please contact our Customer
- Service & Tech Support:orders@biochempartner.com
- Website:www.biochempartner.com
Products are for research use only and not for human use. We do not sell to patients.